Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors

BACKGROUND: New, more effective strategies are needed to treat highly aggressive neuroblastoma. Our laboratory has previously shown that full-length Secreted Protein Acidic and Rich in Cysteine (SPARC) and a SPARC peptide corresponding to the follistatin domain of the protein (FS-E) potently block a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chlenski, Alexandre, Guerrero, Lisa J, Peddinti, Radhika, Spitz, Jared A, Leonhardt, Payton T, Yang, Qiwei, Tian, Yufeng, Salwen, Helen R, Cohn, Susan L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895596/
https://www.ncbi.nlm.nih.gov/pubmed/20525313
http://dx.doi.org/10.1186/1476-4598-9-138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895596/
https://www.ncbi.nlm.nih.gov/pubmed/20525313
http://dx.doi.org/10.1186/1476-4598-9-138

Ejemplares similares